Aew Uk Reit Regulatory News (AEWU)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR INTO OR FROM THE UNITED STATES, OR INTO OR FROM AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA

10 December 2015

AEW UK REIT plc

Results of Placing

The Board of AEW UK REIT plc (the "Company") is pleased to announce that the Company has raised gross proceeds of £17.18 million pursuant to the placing of Shares which closed on 9 December 2015, at an issue price of 101p per Share (the "Placing"). A total of 17,010,000 Shares will be issued, subject only to Admission, on 15 December 2015.

Application has been made for these Shares to be admitted to trading on the Main Market of the London Stock Exchange plc and to listing on the premium segment of the Official List of the UK Listing Authority ("Admission"). It is expected that Admission will become effective, and that dealings in the new Shares will commence, on 15 December 2015. 

For the avoidance of doubt, the new Shares issued pursuant to the Placing will not qualify for the first and second interim dividends which both have a record date of 11 December 2015.

Dexion Capital plc acted as sole sponsor and sole bookrunner in respect of the Placing.

Following this issue of Shares, the Company's issued share capital will consist of 117,510,000 Shares. Accordingly the total number of voting rights in the Company will be 117,510,000 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Terms used and not defined in this announcement shall have the meaning given in the Prospectus which was published by the Company on 23 April 2015 (the "Prospectus") unless the context otherwise requires.

Enquiries

For further information please contact:

Important Information

The distribution of this announcement and the Placing in certain jurisdictions may be restricted by law. No action has been taken by the Company or the Investment Manager or Dexion Capital plc ("Dexion") that would permit an offering of the Shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company, the Investment Manager and Dexion to inform themselves about, and to observe, such restrictions.

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or with any securities or regulatory authority of any state or other jurisdiction of the United States and the Shares may not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. Persons (as defined in Regulation S under the U.S. Securities Act), except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction in the United States. There will be no public offer of the Shares in the United States. The Shares are being offered or sold only outside the United States to non U.S. Persons in offshore transactions in reliance on the exemption from the registration requirements of the U.S. Securities Act provided by Regulation S thereunder. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the "U.S. Investment Company Act") and investors will not be entitled to the benefits of the U.S. Investment Company Act.

Recipients of this announcement are reminded that applications for Shares may be made solely on the basis of the information and opinions contained in the Prospectus dated.

No representation or warranty, express or implied, is made or given by or on behalf of the Company or the Investment Manager or Dexion or any of their respective directors, partners, officers, employees, agents or advisers or any other person (whether or not referred to in this announcement) as to the accuracy, completeness or fairness of the information contained herein and no responsibility or liability is accepted by any of them for any such information or opinions.

No offer or invitation to subscribe for or acquire shares in the Company is being made by or in connection with this announcement.

Dexion, which is authorised and regulated in the United Kingdom by the FCA is acting exclusively for the Company and for no-one else in connection with the arrangements referred to in this announcement and will not regard any other person as a client in relation to such arrangements and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Dexion, nor for providing advice in connection with the arrangements referred to in this announcement.